Sound analysis of the magnetically levitated left ventricular assist device HeartMate 3™

Introduction: The HeartMate 3™ has shown lower rates of adverse events compared to previous devices due to the design and absence of mechanical bearings. For previous devices, sound analysis emerged as a way to assess pump function. The aims of this study were to determine if sound analysis can be applied to the HeartMate 3 in vivo and in vitro and to evaluate an electronic stethoscope. Method: Sound recordings were performed with microphones and clinical accessible electronic stethoscope. The recordings were studied in both the time and the frequency domains. Recordings from four patients were performed to determine if in vivo and in vitro recordings are comparable. Results: The results show that it is possible to detect sound from HeartMate 3 and the sound spectrum is clear. Pump frequency and frequency of the pulsatile mode are easily determined. Frequency spectra from in vitro and in vivo recordings have the same pattern, and the major proportion (96.7%) of signal power is located at the pump speed frequency ±40 Hz. The recordings from the patients show low inter-individual differences except from location of peaks originating from pump speed and harmonics. Electronic stethoscopes could be used for sound recordings, but the dedicated equipment showed a clearer sound spectrum. Discussion: The results show that acoustic analysis can also be performed with the HeartMate 3 and that in vivo and in vitro sound spectrum is similar. The frequency spectra are different from previous devices, and methods for assessing pump function or thrombosis need further evaluation.

[1]  Sean Pinney,et al.  Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  Ivan Netuka,et al.  Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial , 2017, Journal of Cardiothoracic Surgery.

[3]  Shuji Tanaka,et al.  Estimation of early-stage malfunction using implantable artificial heart sound in animal experiments. , 2006, Artificial organs.

[4]  Birgit Glasmacher,et al.  An acoustic method for systematic ventricular assist device thrombus evaluation with a novel artificial thrombus model. , 2018, Journal of thoracic disease.

[5]  Gregory A. Ewald,et al.  A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure , 2017, The New England journal of medicine.

[6]  Nir Uriel,et al.  Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  E. Fosse,et al.  LVAD Thrombosis Detection Using Third Harmonic Frequency Measured With 3D Accelerometer , 2015 .

[8]  J. Losman The International Society for Heart Transplantation , 1982 .

[9]  M. Morshuis,et al.  Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. , 2015, Journal of the American College of Cardiology.

[10]  Michael A Sobieski,et al.  Utilization of acoustic signatures to identify HeartMate XVE device end-of-life. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  D. Rodgers,et al.  Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3). , 2017, The Journal of Heart and Lung Transplantation.

[12]  Hans Granfeldt,et al.  Acoustic Analysis of a Mechanical Circulatory Support , 2013, Artificial organs.

[13]  Nader Moazami,et al.  An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  J. Cleveland,et al.  Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  James W Long,et al.  Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.

[16]  M. Mehra,et al.  The vexing problem of thrombosis in long-term mechanical circulatory support. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  M. Mehra,et al.  Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  C. Bara,et al.  Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. , 2014, JACC. Heart failure.

[19]  Axel Haverich,et al.  First implantation in man of a new magnetically levitated left ventricular assist device (HeartMate III). , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  M. Morshuis,et al.  Long‐term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure—two‐year results from the HeartMate 3 CE Mark Study , 2018, European journal of heart failure.

[21]  Roland Hetzer,et al.  Acoustic Spectral Analysis for Determining Pump Thrombosis in Rotary Blood Pumps , 2014, ASAIO journal.

[22]  Robert L Kormos,et al.  Seventh INTERMACS annual report: 15,000 patients and counting. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  J.,et al.  The New England Journal of Medicine , 2012 .

[24]  Takeshi Nakatani,et al.  Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  Thomas J Royston,et al.  Acoustic Characterization of Axial Flow Left Ventricular Assist Device Operation In Vitro and In Vivo , 2016, ASAIO journal.

[26]  M. Walsh,et al.  A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report , 2019, The New England journal of medicine.